… Marie-Ève Goyer reports payments from Indivior, Gilead Sciences, ViiV Healthcare and
Merck, outside of the submitted work. Julie Bruneau reports monetary compensation as advisor …

“COVID just kind of opened a can of whoop-ass”: The rapid growth of safer supply prescribing
during the pandemic documented through an environmental scan of addiction and harm …

… Competing interests: Marie-Ève Goyer reports receiving an honorarium and training from
Gilead Sciences, outside of the submitted work. Bernard Le Foll reports receiving grants from …

Background: Injectable opioid agonist treatment (iOAT) is an emerging evidence-based
option in the continuum of care for opioid use disorder in parts of Canada. Our study objective …

Those experiencing homelessness in Canada are impacted inequitably by COVID-19 due to
their increased exposure, vulnerability of environment and medical comorbidities, and their …

Introduction : Les personnes en situation de précarité et présentant un usage d’opioïdes
sont confrontées à de nombreuses barrières à l’accès et à la rétention en soin. Des services …

Background The dual COVID-19 and overdose emergencies amplified strain on healthcare
systems tasked with responding to both. One downstream consequence of the pandemic in …

Background Engagement of health care professionals represents an important factor for
successful implementation of new practices. To support these professionals’ involvement, it is …

Background Opioid use is escalating in North America and comes with a multitude of health
consequences, including HIV and hepatitis C virus (HCV) outbreaks among persons who …

Cet article recense les rôles adoptés par les pairs dans le domaine des services aux
personnes qui utilisent des drogues par injection (notamment en lien avec l’éducation, l’intervention…